Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;71(4 Pt 1):324-31.
doi: 10.1038/pr.2011.79. Epub 2012 Feb 15.

Enteral leucine supplementation increases protein synthesis in skeletal and cardiac muscles and visceral tissues of neonatal pigs through mTORC1-dependent pathways

Affiliations

Enteral leucine supplementation increases protein synthesis in skeletal and cardiac muscles and visceral tissues of neonatal pigs through mTORC1-dependent pathways

Agus Suryawan et al. Pediatr Res. 2012 Apr.

Abstract

Introduction: Leucine (Leu) activates mammalian target of rapamycin (mTOR) to upregulate protein synthesis (PS).

Results: PS in skeletal muscles, heart, liver, pancreas, and jejunum, but not kidney, were greater in low protein supplemented with Leu (LP+L) than LP, but lower than high protein (HP). In longissimus dorsi muscle, protein kinase B phosphorylation was similar in LP and LP+L, but lower than HP. Although less than HP, p70 ribosomal S6 kinase 1 (S6K1) and eukaryotic initiation factor (eIF) 4E binding protein 1 (4EBP1) association with regulatory associated protein of mammalian target of rapamycin was greater in LP+L than LP, resulting in higher S6K1 and 4EBP1 phosphorylation. Feeding LP+L vs. LP decreased 4EBP1·eIF4E and increased eIF4E·eIF4G formation, but not to HP. Similar results were obtained for S6K1 and 4EBP1 phosphorylation in gastrocnemius, masseter, heart, liver, pancreas, and jejunum, but not kidney. eIF2α and elongation factor 2 phosphorylation was unaffected by treatment. DICUSSION: Our results suggest that enteral Leu supplementation of a low protein diet enhances PS in most tissues through mTOR complex 1 pathways.

Methods: To examine enteral Leu effects on PS and signaling activation, 5-d-old piglets were fed for 24 h diets containing: (i) LP, (ii) LP+L, or (iii) HP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Circulating insulin (A), glucose (B), and BCAA (C) concentrations in piglets fed LP (●), LP+L (○), and HP (▲) diets every 4 h for 24 h. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differ, p < 0.05.
Figure 2
Figure 2
Plasma concentrations of essential AA (A) and nonessential AA (B) in piglets fed LP (□), LP+L (■), or HP ( formula image) diets for 1530 min. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differ, p < 0.05.
Figure 3
Figure 3
PS rates (A) and phosphorylation of PKB (B), S6K1 (C) and 4EBP1 (D) in longissimus dorsi muscle of piglets fed LP (□), LP+L (■), or HP ( formula image) diets. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differed, p < 0.05.
Figure 4
Figure 4
Abundance of raptor·mTOR (A), raptor·PRAS40 (B), raptor·S6K1 (C) and raptor·4EBP1 (D) complexes in longissimus dorsi muscle of piglets fed LP (□), LP+L (■), or HP ( formula image) diets. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differed, P < 0.05.
Figure 5
Figure 5
Abundance of eIF4E·4EBP1 (A) and eIF4E·eIF4G (B), and phosphorylation of eIF2α (C) and eEF2 (D) in longissimus dorsi muscle of piglets fed LP (□), LP+L (■), or HP ( formula image) diets. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differed, p < 0.05.
Figure 6
Figure 6
PS rates in gastrocnemius (A), masseter (B), and heart (C) muscles of piglets fed LP (□), LP+L (■), or HP ( formula image) diets. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differed, p < 0.05.
Figure 7
Figure 7
PS rates in liver (A), pancreas (B), jejunum (C), and kidney (D) of piglets fed LP (□), LP+L (■), or HP ( formula image) diets. Values are means + SEM, n = 7–10 per treatment. Means without a common symbol differed, p < 0.05.

References

    1. Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics. 1991;87:587–597. - PubMed
    1. Hack M, Fanaroff AA. Outcomes of extremely-low-birth-weight infants between 1982 and 1988. N Engl J Med. 1989;321:1642–1647. - PubMed
    1. Ehrenkranz RA, Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL, Katsikiotis V, Tyson JE, Oh W, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics. 1999;104:280–289. - PubMed
    1. Ford GW, Doyle LW, Davis NM, Callanan C. Very low birth weight and growth into adolescence. Arch Pediatr Adolesc Med. 2000;154:778–784. - PubMed
    1. Peralta-Carcelen M, Jackson DS, Goran MI, Royal SA, Mayo MS, Nelson KG. Growth of adolescents who were born at extremely low birth weight without major disability. J Pediatr. 2000;136:633–640. - PubMed

Publication types

MeSH terms